Scabies and pediculosis

Lancet

Volumn 355, Issue 9206, 2000, Pages 819-826

  Chosidow, Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL BENZOATE; CROTAMINE; DISULFIRAM; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; PYRETHRIN; STEROID;

BULLOUS SKIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HOMELESSNESS; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; NONHUMAN; NURSING HOME; PEDICULOSIS; PRIORITY JOURNAL; REVIEW; RICKETTSIOSIS; SCABIES; SIDE EFFECT; SKIN DISEASE; TYPHUS;

EID: 0034603338     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)09458-1     Document Type: Review

References (64)

1. Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29: 1226-30.
2. Orkin M. Scabies: what's new? Curr Probl Dermatol 1995; 22: 105-11.
3. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic health care institutions. Arch Dermatol 1992; 128: 1257-60.
4. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7: 67-73.
5. Codington HB, Coghian SE. Lindane for scabies in Bangladesh. Lancet 1993; 342: 677-78.
6. Hegazy AA, Darwish NM, Abdel-Hamid A, Hammad SM. Epidemiology and control of scabies in an Egyptian village. Int J Dermatol 1999; 38: 291-95.
7. Portu JJ, Santamaria JM, Zubero Z, et al. Atypical scabies in HIV-positive patients. J Am Acad Dermatol 1996; 34: 915-17.
8. Del Giudice P, Sainte Marie D, Gérard Y, Couppié P, Pradinaud R. Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J Infect Dis 1997; 176: 1090-92.
9. Mancini AJ, Frieden IJ, Paller AS. Scabies and infantile acropustulosis are difficult to differentiate from one another. Pediatr Dermatol 1998; 15: 337-41.
10. Meyers LN. Clinical presentation of scabies in a nursing home population. J Am Acad Dermatol 1988; 18: 396-97.
11. Farrell AM, Ross JS, Bunker CB, Staughton RCD. Crusted scabies with scalp involvement in HIV-1 infection. Br J Dermatol 1998; 138: 192-93.
12. Alinovi A, Pretto ME. Scabietic infestation of the scalp: a clue for puzzling relapses. J Am Acad Dermatol 1994; 31: 491-93.
13. Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy: a new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 1997; 133: 751-53.
14. Schultz MW, Gomez M, Hansen RC, et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990; 126: 167-70.
15. Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901-05.
16. Meinking TL, Taplin D. Safety of permethrin vs lindane for the treatment of scabies. Arch Dermatol 1996; 132: 959-62.
17. Burns DA. Scabies. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of dermatology, 6th edn. Oxford: Blackwell Science, 1998: 1458-65.
18. Youssef MYM, Sadaka HAH, Eissa MM, El-Ariny AF. Topical application of ivermectin for human ectoparasites. Am J Trop Med Hyg 1995; 53: 652-53.
19. Taplin D, Porcelain SL, Meinking TL, et al. Community control of scabies: a model on use of permethrin cream. Lancet 1991; 337: 1016-18.
20. Del Guidice P, Marty P. Ivermectin: a new therapeutic weapon in dermatology? Arch Dermatol 1999; 135: 705-06.
21. Macotela-Ruiz E, Pena-Gonzalez G. Tratamiento de la escabiasis con ivermectina por via oral. Gac Med Mex 1993; 129: 201-05.
22. Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia-Pelat JP, Martin PMV. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44: 331-32.
23. Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135: 651-55.
24. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26-30.
25. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144-45.
26. Del Giudice P, Marty P, Gari-Toussaint M, Le Fichoux Y. Ivermectin in the elderly patients. Arch Dermatol 1999; 135: 351-52.
27. Burkhart KM, Burkhart CN, Burkhart CG. Comparing topical scabietic treatments will soon become extinct. Arch Dermatol 1997; 133: 1314.
28. Quaterman MJ, Lesher JL Jr. Neonatal scabies treated with permethrin 5% cream. Pediatr Dermatol 1994; 11: 264-66.
29. Judge MR, Kobza-Black A. Crusted scabies in pregnancy. Br J Dermatol 1995; 132: 116-19.
30. Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med 1995; 332: 612.
31. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12: 26-33.
32. Zias J, Mumcuoglu KY. Pre-pottery neolithic B head lice from Nahal Hemar Cave. Atigot 1991; 20: 167-68.
33. Capasso L, Di Tota G. Lice buried under the ashes of Herculaneum. Lancet 1998; 351: 992.
34. Mumcuoglu KY, Klaus S, Kafka D, Teiler M, Miller J. Clinical observations related to head lice infestation. J Am Acad Dermatol 1991; 25: 248-51.
35. Jorm LR, Capon AG. Communicable disease outbreaks in long day care centres in western Sydney: occurrence and risk factors. J Pediatr Child Health 1994; 30: 151-54.
36. Gillis D, Slepon R, Karsenty E, Green M. Seasonality and long-term trends of pediculosis capitis and pubis in a young adult population. Arch Dermatol 1990; 126: 638-41.
37. Burns DA. Lice. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of dermatology, 6th edn. Oxford: Blackwell Science, 1998: 1438-45.
38. Roux V, Raoult D. Body lice as tools for diagnosis and surveillance of reemerging diseases. J Clin Microbiol 1999; 37: 596-99.
39. Drancourt M, Mainardi JL, Brouqui P, et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless patients. N Engl J Med 1995; 332: 419-23.
40. Raoult D, Ndihokubwayo JB, Tissot-Dupont H, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 1998; 352: 353-58.
41. Brouqui P, Lascola B, Roux V, Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 1999; 340: 184-89.
42. Tarasevich I, Rydkina E, Raoult D. Outbreak of epidemic typhus in Russia. Lancet 1998; 352: 1151.
43. Sundnes KO, Haimanot AT. Epidemic of louse-borne relapsing fever in Ethiopia. Lancet 1993; 342: 1213-15 (correction Lancet 1994; 343: 244).
44. Meinking TL, Taplin D. Infestations: pediculosis. Curr Probl Dermatol 1996; 24: 157-63.
45. Lord WD, DiZinno JA, Wilson MR, Budowle B, Taplin D, Meinking TL. Isolation, amplification and sequencing of human mitochondrial DNA obtained from human crab louse, Pthirus pubis (L), blood meals. J Forensic Sci 1998; 43: 1097-100.
46. Courtiade C, Labrèze C, Fontan I, Taïeb A, Maleville J. La pédiculose du cuir chevelu: enquête par questionnaire dans quatre groupes scolaires d l'Académie de Bordeaux en 1990-1991. Ann Dermatol Venereol 1993; 120: 363-68.
47. Downs AM, Stafford KA, Harvey I, Coles G. Evidence for double resistance to permethrin and malathion in head lice. Br J Dermatol 1999; 41: 508-11.
48. Choudary S. Burns due to anti-lice lotion. Burns 1999; 25: 184-85.
49. Abramowicz M. Malathion for treatment of head lice. Med Lett Drugs Ther 1999; 41: 73-74.
50. Dennis GA, Lee PN. A phase I volunteer study to establish the degree of absorption and effect on cholinesterase activity of four head lice preparations containing malathion. Clin Drug Invest 1999; 18: 105-15.
51. Hemingway J, Miller J, Mumcuoglu KY. Pyrethoid resistance mechanisms in the head louse Pediculus capitis from Israel: implications for control. Med Vet Entomol 1999; 13: 89-96.
52. Damschen DD, Carlile JR. A hazard of lay medical treatment for lice. N Engl J Med 1990; 323: 1176.
53. Birtwistle S. Pediculus humanus capitis in schoolchildren. Lancet 1995; 345: 731.
54. Glaziou P, Nyguyen LN, Moulia-Pelat JP, Cartel JL, Martin PM. Efficacy of ivermectin for the treatment of head lice (pediculosis capitis). Trop Med Parasitol 1994; 45: 253-54.
55. Chosidow O, Chastang C, Brue C, et al. Controlled study of malathion and d-phenothrin lotions for Pediculus humanus var copits-infested schoolchildren. Lancet 1994; 344: 1724-27.
56. Burgess IF, Brown CM, Burgess NA. Synergized pyrethrin mousse, a new approach to head lice eradication: efficacy in field and laboratory studies. Clin Ther 1994; 16: 57-64.
57. Clore ER, Longyear LA. A comparative study of seven pediculicides and their packaged nit removal combs. J Pediatr Health Care 1993; 7: 55-60.
58. Vander Stichele RH, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatment for head lice. BMJ 1995; 311: 604-08.
59. Dawes M, Hicks NR, Flemminger M, Goldman D, Hamling J, Hicks LJ. Evidence-based case report: treatment for head lice. BMJ 1999; 318: 385-86.
60. Burkhart CN, Burkhart CG, Pchalek I, Arbogast J. The adherent cylindrical nit structure and its chemical denaturation in vitro: an assessment with therapeutic implications for head lice. Arch Pediatr Adolesc Med 1998; 152: 711-12.
61. Son WY, Pai KS, Huh S. Comparison of two modes of mass delousing in schoolchildren. Pediatr Infect Dis J 1995; 14: 625-26.
62. Burgess IF, Peock S, Brown CM, Kaufman J. Head lice resistant to pyrethroid insecticides in Britain. BMJ 1995; 311: 752.
63. Schachner LA. Treatment resistant head lice: alternative therapeutic approaches. Pediatr Dermatol 1997; 14: 409-10.
64. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med 1999; 153: 969-73.